Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux-Lamy Syndrome

about

Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux-Lamy Syndrome

Item

http://www.wikidata.org/entity/Q42368422

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@en

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@nl

type

Item

label

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@en

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@nl

prefLabel

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@en

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@nl

P1476

Clinical Evolution After Enzym ...... orm of Maroteaux-Lamy Syndrome

@en

P2093

A Fernandez Lopez

http://www.w3.org/2001/XMLSchema#string

G Garcia-Fructuoso

http://www.w3.org/2001/XMLSchema#string

M J Coll

http://www.w3.org/2001/XMLSchema#string

M O'Callaghan

http://www.w3.org/2001/XMLSchema#string

M Pineda

http://www.w3.org/2001/XMLSchema#string

R Ullot

http://www.w3.org/2001/XMLSchema#string

P2860

A NEW DYSOSTOSIS WITH URINARY ELIMINATION OF CHONDROITIN SULFATE B

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

Mucopolysaccharidosis VI.

The frequency of lysosomal storage diseases in The Netherlands.

Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.

Perioperative medullary complications in spinal and extra-spinal surgery in mucopolysaccharidosis: a case series of three patients.

Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy

Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase.

Management guidelines for mucopolysaccharidosis VI.

Mucopolysaccharidosis VI: the Italian experience.

P304

7-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/8904_2016_530

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26920906

http://www.w3.org/2001/XMLSchema#string

P921

Enzyme replacement therapy

P932

5110444

http://www.w3.org/2001/XMLSchema#string